Clinical Trials Directory

Trials / Completed

CompletedNCT02838732

Investigation on the Effect of Carnitine Supplement on Gut Microbiota and TMAO Production Capacity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

In this project, the investigators aim to explore the impact of dietary L-carnitine supplementation on the TMAO production capacity of gut microbiota.

Detailed description

Recent studies have established plasma trimethylamine N-oxide (TMAO) levels as a strong, independent risk factor for cardiovascular disease. TMAO is produced by the interaction between gut microflora and ingested L-carnitine from food. Research indicates that both plasma TMAO concentration and the TMAO production capacity of gut microbiota in vegetarians are significantly lower than in omnivores, likely due to the reduced L-carnitine intake in vegetarian diets. This study aims to explore the impact of L-carnitine supplementation on the TMAO production capacity of human gut microbiota and to identify TMAO-producing bacteria within the gut microflora. The study plans to recruit both omnivore and vegetarian volunteers to undergo a one-month L-carnitine supplementation, followed by an evaluation of changes in TMAO production using an oral L-carnitine challenge test, along with gut microbiota assessment. TMAO concentration will be measured using LC-MS/MS, and gut microbiome analysis will be conducted through shotgun metagenome sequencing. Bioinformatic analysis may reveal potential TMAO-producing bacteria. Understanding the changes in TMAO production and gut microbiota composition post-L-carnitine supplementation may enhance our knowledge of the interplay between L-carnitine supplements, TMAO, and gut microflora.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTL-carnitine supplementation (500 mg per tablet per day, purchased from GNC company)

Timeline

Start date
2016-05-18
Primary completion
2017-11-20
Completion
2019-10-07
First posted
2016-07-20
Last updated
2023-12-18

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT02838732. Inclusion in this directory is not an endorsement.